Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

SSKN / Strata Skin Sciences, Inc. / LEVITICUS PARTNERS L P - 3G/A (Passive Investment)

2017-11-22 sec.gov
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1)* STRATA Skin Sciences, Inc. -------------------------------------------------------------------- (Name of Issuer) Common Stock ------------------------------------------------------------------ (Title of Class of Securities) 86272A107 ---------------------------------------------------------------------- (CUSIP Number) 11/14/2017 -----------------------------------

SSKN / Strata Skin Sciences, Inc. / LEVITICUS PARTNERS L P - 3G/A (Passive Investment)

2017-11-22 sec.gov
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1)* STRATA Skin Sciences, Inc. -------------------------------------------------------------------- (Name of Issuer) Common Stock ------------------------------------------------------------------ (Title of Class of Securities) 86272A107 ---------------------------------------------------------------------- (CUSIP Number) 11/14/2017 -----------------------------------

STRATA Skin Sciences' (SSKN) CEO Frank McCaney on Q3 2017 Results - Earnings Call Transcript

2017-11-10 seekingalpha
Good day and welcome to the STRATA Skin Sciences’ Third Quarter 2017 Earnings Conference Call. Today’s conference is being recorded. (4-0)

BRIEF-Leviticus Partners reports 9.69 pct passive stake in Strata Skin Sciences

2017-11-02 reuters
* Says reports 9.69 pct passive stake in Strata Skin Sciences Inc as of Oct 24, 2017 - SEC filing‍​ Source text - (bit.ly/2h6vUO5) (4-2)

SSKN / Strata Skin Sciences, Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2017-11-02 fintel.io
Strata Skin Sciences, Inc. (NASDAQ:SSKN) has 19 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 836,595 shares. Largest shareholders include Leviticus Partners L P, Sabby Management, Llc, Bridgeway Capital Management Inc, Broadfin Capital, LLC, and BlackRock Inc.. (36-2)

Strata Skin Sciences 3G (Passive Acquisition of More Than 5% of Shares)

2017-11-02 sec.gov
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. )* STRATA Skin Sciences, Inc. -------------------------------------------------------------------- (Name of Issuer) Common Stock ------------------------------------------------------------------ (Title of Class of Securities) 86272A107 ---------------------------------------------------------------------- (CUSIP Number) 10/24/2017 --------------------------------------

Strata Skin Sciences 3G (Passive Acquisition of More Than 5% of Shares)

2017-11-02 sec.gov
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. )* STRATA Skin Sciences, Inc. -------------------------------------------------------------------- (Name of Issuer) Common Stock ------------------------------------------------------------------ (Title of Class of Securities) 86272A107 ---------------------------------------------------------------------- (CUSIP Number) 10/24/2017 --------------------------------------

STRATA Skin Sciences'(SSKN) CEO Frank McCaney on Q2 2017 Results - Earnings Call Transcript

2017-08-10 seekingalpha
Good day and welcome to the STRATA Skin Sciences Second Quarter 2017 Earnings Conference Call. Today's conference is being recorded.

STRATA Skin Sciences' (SSKN) CEO Frank McCaney on Q1 2017 Results - Earnings Call Transcript

2017-05-11 seekingalpha
Good day and welcome to the STRATA Skin Sciences First Quarter 2017 Earnings Conference Call. Today's conference is being recorded. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session and instructions on how to queue will be provided at that time.

Strata Skin Sciences SABBY 13G-A SSKN 1.06.16 (Passive Acquisition of More Than 5% of Shares)

2017-04-06 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* STRATA Skin Sciences, Inc. (formerly MELA Sciences, Inc.) (Name of Issuer) Common Stock (Title of Class of Securities) 86272A107 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d

STRATA Skin Sciences Release: Psoriasis Drugs Among Leaders In Drug Side Effect Reporting

2017-03-31 devicespace
HORSHAM, PA, March 31, 2017 /PRNewswire/ - According to a recent USA Today Network Exclusive analysis*, the number of drug side effect reports filed with the U.S. Food and Drug Administration (FDA) has increased five-fold from 2004 to 2015. This equated to more than 1.2 million reports in 2015.1

STRATA Skin Sciences' (SSKN) CEO Frank McCaney on Q4 2016 Results - Earnings Call Transcript

2017-03-10 seekingalpha
Good day ladies and gentlemen and welcome to the STRATA Skin Sciences Fourth Quarter and Full-Year 2016 Earnings Conference Call. Please note, today’s conference is being recorded.

Strata Skin Sciences STRATA DEFINITIVE PROXY FEBRUARY 2017

2017-02-17 sec.gov
      STRATA SKIN SCIENCES, INC. 100 Lakeside Drive, Suite 100 Horsham, Pennsylvania 19044 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS To Be Held on March 29, 2017 Dear Stockholder: You are cordially invited to attend the Special Meeting of Stockholders of STRATA Skin Sciences, Inc., a Delaware corporation (the "Company"). The meeting will be held at the offices of the Company, 100 Lakeside Drive, Suite 100, Horsham, Pennsylvania 19044 on Wednesday, March 29, 2017 at 9:30 a.


CUSIP: 55277R100